De-Escalating Bone-Modifying Therapy Safe, Effective in Metastatic Breast Cancer

(MedPage Today) — BERLIN — Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be safe in prostate cancer…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118033

Author :

Publish date : 2025-10-20 16:30:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

De-Escalating Bone-Modifying Therapy Safe, Effective in Metastatic Breast Cancer

Europe Has the Tools — So Why Are HIV Targets Off Track?

SLGT2 Inhibitors Tied to Less Progression of Lung Lesions

Related Posts

Pazdur Tells of FDA Turmoil; Surgeon’s Data Questioned; MAHA’s Supplement Boom

Supplement Yanked Over Suicide Risk; ‘Dilbert’ Creator Dies; Full-Body Scan Lawsuit

China has applied to launch 200,000 satellites, but what are they for?

More People Survive Cancer, Report Shows

Are Cardiologists Overlooking Substance Use Risk?

‘It’s life-changing. I can see my child grow up’

Pazdur Tells of FDA Turmoil; Surgeon’s Data Questioned; MAHA’s Supplement Boom

Supplement Yanked Over Suicide Risk; ‘Dilbert’ Creator Dies; Full-Body Scan Lawsuit

China has applied to launch 200,000 satellites, but what are they for?

More People Survive Cancer, Report Shows

Are Cardiologists Overlooking Substance Use Risk?

‘It’s life-changing. I can see my child grow up’

Sleeping With the Light on May Increase Heart Disease Risk

Axillary Nerve Block May Be Viable for ED Fracture Reduction

Categories

Archives